Home > A. Molecular pathology > Targeted therapy > Pathway-targeted therapy > PI3K pathway inhibitors
PI3K pathway inhibitors
Sunday 5 January 2014
Open references
Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Andersen JN, Sathyanarayanan S, Di Bacco A, Chi A, Zhang T, Chen AH, Dolinski B, Kraus M, Roberts B, Arthur W, Klinghoffer RA, Gargano D, Li L, Feldman I, Lynch B, Rush J, Hendrickson RC, Blume-Jensen P, Paweletz CP. Sci Transl Med. 2010 Aug 4;2(43):43ra55. doi : 10.1126/scitranslmed.3001065 PMID: 20686178 [Free]